Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Looks To Bolster Dexatrim Line With New Bar, R&D

This article was originally published in The Tan Sheet

Executive Summary

Chattem says it has created a strong new line extension for its Dexatrim weight-loss products with the launch of the Dexatrim All In One bar in the second quarter

You may also be interested in...



PLMA In Brief

Perrigo: Private labeler unveils Nasal Decongestant PE (phenylephrine 10 mg) in preparation for launch in the first half of 2005 at the Private Label Manufacturers Association trade show in Chicago Nov. 14-16. The 18-count tablets offer a decongestant alternative to solid tablet pseudoephedrine, Perrigo says. However, the product will face competition from same-ingredient private-label entries by Leiner and PL Developments, also slated to debut in early 2005 (see 1following story). Perrigo additionally plans pseudoephedrine 30 mg liquid caps and 15 mg grape-flavored syrup, as well as several new acetaminophen products for introduction in the in the first half of the year. The Allegan, Mich.-based firm also features Century Carb Multi (comparable to Wyeth's Centrum Carb Assist) in 45-tablet bottles and a store brand nutritional drink with plant sterols (equivalent to Abbott Labs' Ensure) in 6-8 oz. cans at the show...

PLMA In Brief

Perrigo: Private labeler unveils Nasal Decongestant PE (phenylephrine 10 mg) in preparation for launch in the first half of 2005 at the Private Label Manufacturers Association trade show in Chicago Nov. 14-16. The 18-count tablets offer a decongestant alternative to solid tablet pseudoephedrine, Perrigo says. However, the product will face competition from same-ingredient private-label entries by Leiner and PL Developments, also slated to debut in early 2005 (see 1following story). Perrigo additionally plans pseudoephedrine 30 mg liquid caps and 15 mg grape-flavored syrup, as well as several new acetaminophen products for introduction in the in the first half of the year. The Allegan, Mich.-based firm also features Century Carb Multi (comparable to Wyeth's Centrum Carb Assist) in 45-tablet bottles and a store brand nutritional drink with plant sterols (equivalent to Abbott Labs' Ensure) in 6-8 oz. cans at the show...

PLMA In Brief

Perrigo: Private labeler unveils Nasal Decongestant PE (phenylephrine 10 mg) in preparation for launch in the first half of 2005 at the Private Label Manufacturers Association trade show in Chicago Nov. 14-16. The 18-count tablets offer a decongestant alternative to solid tablet pseudoephedrine, Perrigo says. However, the product will face competition from same-ingredient private-label entries by Leiner and PL Developments, also slated to debut in early 2005 (see 1following story). Perrigo additionally plans pseudoephedrine 30 mg liquid caps and 15 mg grape-flavored syrup, as well as several new acetaminophen products for introduction in the in the first half of the year. The Allegan, Mich.-based firm also features Century Carb Multi (comparable to Wyeth's Centrum Carb Assist) in 45-tablet bottles and a store brand nutritional drink with plant sterols (equivalent to Abbott Labs' Ensure) in 6-8 oz. cans at the show...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096982

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel